These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12053928)

  • 21. [Deficient documentation in the guidelines for antibiotics use].
    Andresen LK
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):540; author reply 540-1. PubMed ID: 19282894
    [No Abstract]   [Full Text] [Related]  

  • 22. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.
    Vogel A; Lennon D; Best E; Leversha A
    N Z Med J; 2016 Oct; 129(1443):77-83. PubMed ID: 27736855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impetigo in French Guyana. A clinical, bacteriological, toxicological and sensitivity to antibiotics study].
    Couppié P; Sainte-Marie D; Prévost G; Gravet A; Clyti E; Moreau B; Monteil H; Pradinaud R
    Ann Dermatol Venereol; 1998 Oct; 125(10):688-93. PubMed ID: 9835957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy of josamycin in the treatment of impetigo in children and its in vitro activity on erythromycin resistant Staphylococcus aureus strains.
    Mosca A; Del Prete R; Mazzotta F; Bonifazi E; Miragliotta G
    J Chemother; 1995 Nov; 7 Suppl 4():158-9. PubMed ID: 8904141
    [No Abstract]   [Full Text] [Related]  

  • 25. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
    Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
    Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusidic acid resistance in Staphylococcus aureus.
    Dobie D; Gray J
    Arch Dis Child; 2004 Jan; 89(1):74-7. PubMed ID: 14709515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study.
    Osterlund A; Kahlmeter G; Haeggman S; Olsson-Liljequist B;
    Scand J Infect Dis; 2006; 38(5):334-4. PubMed ID: 16724423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
    Apisarnthanarak A; Mundy LM
    Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
    Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Managing children skin and soft tissue infections].
    Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway.
    Tveten Y; Jenkins A; Kristiansen BE
    J Antimicrob Chemother; 2002 Dec; 50(6):873-6. PubMed ID: 12461006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.
    O'Neill AJ; Larsen AR; Skov R; Henriksen AS; Chopra I
    J Clin Microbiol; 2007 May; 45(5):1505-10. PubMed ID: 17344365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusidic acid: new opportunities with an old antibiotic.
    Anderson JD
    Can Med Assoc J; 1980 Apr; 122(7):765-9. PubMed ID: 6988070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of skin bacterial colonisation, susceptibility and resistance in atopic dermatitis and impetigo patients.
    Salah LA; Faergemann J
    Acta Derm Venereol; 2015 May; 95(5):532-5. PubMed ID: 25367860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
    Peeters KA; Mascini EM; Blok HE; Sanders CJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population.
    Rørtveit S; Rortveit G
    Br J Dermatol; 2007 Jul; 157(1):100-5. PubMed ID: 17553056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of Fucidin Ointment and Cicatrin Cream in the treatment of impetigo.
    Cassels-Brown G
    Br J Clin Pract; 1981 Apr; 35(4):153-5. PubMed ID: 7028065
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia.
    Alreshidi MA; Mariana NS
    Med J Malaysia; 2011 Aug; 66(3):276. PubMed ID: 22111461
    [No Abstract]   [Full Text] [Related]  

  • 40. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
    Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
    Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.